A strategic partner of Afriplex, House of Hemp, has received its Cannabis cultivation license from the South African Health Products Regulatory Authority (SAHPRA). This is a historical milestone for South Africa to become an active and innovative player in the budding cannabis market. It also marks a positive move forward by SAHPRA to encourage the development of the medical cannabis and cannabidiol (CBD) sector.
A growing body of medical research, both locally and globally, points to the recognition of cannabis – and especially CBD use – for patients needing to manage diseases like cancer (and the side effects of chemotherapy), epilepsy and seizures, post-traumatic stress disorder (PTSD), glaucoma, dementia, Alzheimer’s, autism, fibromyalgia and a range of auto-immune diseases.
Paving the way to standardisation
SAHPRA’s granting of the license sets in motion a process that will eventually see the standardisation and proper scientific formulation, dosage requirements and combinations of cannabinoids for medical purposes. It not only offers the opportunity to improve the lives of patients with life-challenging conditions in a safe and effective way, but also to enhance the general wellbeing of a larger community of patients struggling with more general ailments like pain, inflammation, appetite stimulation, sleep quality, nausea and asthma.
With the current global market value for medicinal cannabis estimated at USD8.28 billion – and expected to reach USD27 billion by 2024, the medical cannabis industry holds formidable economic development potential for South Africa.
An honourable first for SA
‘Afriplex and our strategic partner, House of Hemp, are extremely honoured to be associated with the first Cannabis License from SAHPRA,’ says Danie Nel, Afriplex CEO. ‘The teams have worked tirelessly over the last seven years to ensure we meet local standards and the legislative requirements and quality standards of international markets. Being the first in South Africa to receive this accreditation enables us to actively pursue expansion into the global cannabis market.’